Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Harlan

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Investigation|October 7, 2004
Challenges facing islet transplantation for the treatment of type 1 diabetes mellitusKristina I Rother, David M Harlan
Diabetes|December 1, 2010
Comment on: Keenan et al. (2010) residual insulin production and pancreatic ß-Cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 2010;59:2846-2853Kristina I Rother, David M Harlan
The New England Journal of Medicine|May 14, 2004
Islet transplantation as a treatment for diabetesDavid M Harlan, Kristina I Rother
The New England Journal of Medicine|November 12, 2010
Infant formula, autoimmune triggers, and type 1 diabetesDavid M Harlan, Mary M Lee
The Journal of Family Practice|October 22, 2013
Diabetes: 8 strategies to put into practiceRonald N Adler, David M Harlan,
Annals of the New York Academy of Sciences|March 23, 2007
Cytotoxic T cell-mediated diabetes in RIP-CD80 transgenic mice: autoantigen peptide sensitivity and fine specificityKlaus Pechhold, Sagarika Chakrabarty, David M Harlan
Diabetes/Metabolism Research and Reviews|June 6, 2003
Islet transplantation: where do we stand now?Boaz Hirshberg, Kristina I Rother, David M Harlan
Current Diabetes Reports|October 22, 2016
Redesigning Diabetes Care: Defining the Role of Endocrinologists Among Alternative ProvidersSamir Malkani, Sheri A Keitz, David M Harlan
Cell Systems|October 28, 2016
Surprising Heterogeneity of Pancreatic Islet Cell SubsetsDavid M Blodgett, Sambra D Redick, David M Harlan
Discovery Medicine|August 14, 2010
Islet transplantation and the challenges of treating type 1 diabetesEric H Liu, Kristina I Rother, David M Harlan
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Investigation|October 7, 2004
Challenges facing islet transplantation for the treatment of type 1 diabetes mellitusKristina I Rother, David M Harlan
Diabetes|December 1, 2010
Comment on: Keenan et al. (2010) residual insulin production and pancreatic ß-Cell turnover after 50 years of diabetes: Joslin Medalist Study. Diabetes 2010;59:2846-2853Kristina I Rother, David M Harlan
The New England Journal of Medicine|May 14, 2004
Islet transplantation as a treatment for diabetesDavid M Harlan, Kristina I Rother
The New England Journal of Medicine|November 12, 2010
Infant formula, autoimmune triggers, and type 1 diabetesDavid M Harlan, Mary M Lee
The Journal of Family Practice|October 22, 2013
Diabetes: 8 strategies to put into practiceRonald N Adler, David M Harlan,
Annals of the New York Academy of Sciences|March 23, 2007
Cytotoxic T cell-mediated diabetes in RIP-CD80 transgenic mice: autoantigen peptide sensitivity and fine specificityKlaus Pechhold, Sagarika Chakrabarty, David M Harlan
Diabetes/Metabolism Research and Reviews|June 6, 2003
Islet transplantation: where do we stand now?Boaz Hirshberg, Kristina I Rother, David M Harlan
Current Diabetes Reports|October 22, 2016
Redesigning Diabetes Care: Defining the Role of Endocrinologists Among Alternative ProvidersSamir Malkani, Sheri A Keitz, David M Harlan
Cell Systems|October 28, 2016
Surprising Heterogeneity of Pancreatic Islet Cell SubsetsDavid M Blodgett, Sambra D Redick, David M Harlan
Discovery Medicine|August 14, 2010
Islet transplantation and the challenges of treating type 1 diabetesEric H Liu, Kristina I Rother, David M Harlan
Pageof 12